ALEXANDRIA, Va., June 12 -- United States Patent no. 12,298,318, issued on May 13, was assigned to Texas Children's Hospital (Houston) and Baylor College of Medicine (Houston).
"Targeting ligands for tau pathology" was invented by Parag Parekh (Houston) and Ananth Annapragada (Manvel, Texas).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for detecting tau pathology are described. The compositions for detecting tau pathology comprise a targeting ligand that specifically binds to a cell surface marker of tau pathology, wherein the targeting ligand is linked to a liposome that includes an imaging agent. The compositions can be used in a method for imaging tau pathology in a subject that ...